Buchumschlag

Inhibition of Growth and Induction of Apoptosis of Human Prostate Cancer Cells by Enzymatic Blockage of Kallikreins

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Fabienne Lehner, Souzan Salemi, Christopher Millan, Christoph Kündig, Daniel Eberli
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2026
Schlagworte:	Prostate Cancer
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

In Vitro Effects of Cabazitaxel and Menadione on Cell Growth, Metabolism, and Transcriptomic Profile of Human Prostate Cancer Cell Lines
von: Ana Laura Gómez-Rosas, et al.
Veröffentlicht: (2026)

The Impact of Tumor Microenvironmental Acidity on Bicalutamide Sensitivity in Prostate Cancer Cells
von: Pedram Golmohammadi, et al.
Veröffentlicht: (2026)

Metformin and Flutamide Combination Therapy’s Efficacy and Safety in Prostate Cancer Cell Lines
von: AhmadReza Rezaeian, et al.
Veröffentlicht: (2026)

Autocrine Fibroblast Growth Factor Receptor 1 Signaling Activates Lactate Dehydrogenase A‐Aerobic Glycolysis for Advanced Human Prostate Tumor Growth
von: Xiaoming Xu, et al.
Veröffentlicht: (2025)

Determinants of the Cost of Illness in Iranian Prostate Cancer Patients
von: Ramin Ravangard, et al.
Veröffentlicht: (2026)

Number of Prescription Medications and Overall Survival in Metastatic Castrate‐Resistant Prostate Cancer
von: Carley R. Pickett, et al.
Veröffentlicht: (2024)

Development of Mouse‐Tumor Model Using Prostate Cancer (PC3) Cell Line for High‐Intensity Focused Ultrasound (HIFU) Ablation
von: Nabin Khanal, et al.
Veröffentlicht: (2025)

Skeletal Muscle Loss During Treatment With Abiraterone in Patients With Metastatic Prostate Cancer
von: Eva Streckova, et al.
Veröffentlicht: (2025)

Providing a Prostate Cancer Detection and Prevention Method With Developed Deep Learning Approach
von: Alireza Zarei, et al.
Veröffentlicht: (2025)

Preliminary Evidence on Safety and Clinical Efficacy of Luteolin for Patients With Prostate Cancer Under Active Surveillance
von: Taku Naiki, et al.
Veröffentlicht: (2025)

MRI‐Determined Tumor Contact Area as a Predictor of Pathological Extraprostatic Extension in Clinical T2 Prostate Cancer
von: Masashi Tsujimoto, et al.
Veröffentlicht: (2025)

Evaluation of Second‐Line Treatment for Castration‐Resistant Prostate Cancer following the Administration of Upfront Androgen Receptor Signaling Inhibitors
von: Kazuro Kikkawa, et al.
Veröffentlicht: (2024)

Change in Clinical Management of Localized Prostate Cancer Patients at a Tertiary Medical Center as a Result of SARS‐CoV‐2 (COVID‐19)
von: Alexander Yaney, et al.
Veröffentlicht: (2026)

Real‐World Treatment Patterns Before and After Metastatic Castration–Resistant Prostate Cancer in Japan: Retrospective Analysis Using a Hospital‐Based, Multicenter Database
von: Masaki Shiota, et al.
Veröffentlicht: (2026)

Dorsomorphin Suppresses EMT to Reduce AR‐Negative Prostate Cancer Metastasis by Synergistically Antagonizing JAK2/STAT3 and Gli2‐Independent Shh Activation
von: Dongzhang Li, et al.
Veröffentlicht: (2025)

Reliability of Negative Prostate MRI for Biopsy Decision‐Making in the Male Han Chinese Population
von: Fangming Wang, et al.
Veröffentlicht: (2026)

Immunohistochemical Detection of CD147 Expression in Adenocarcinoma of the Prostate: A Case‐Control Study
von: Sara Suliman, et al.
Veröffentlicht: (2024)

Surgical Wait Time Is Not Associated With Oncological or Psychosocial Outcomes After Robotic Radical Prostatectomy
von: Juliette Cotte, et al.
Veröffentlicht: (2025)

IL7 as a Risk Factor for Prostate Cancer: Implications for T Cell Apoptosis and Infiltration in the Tumor Microenvironment
von: Enyang He, et al.
Veröffentlicht: (2024)

Erratum to “Inhibition of Signaling Downstream of Beta‐2 Adrenoceptor by Propranolol in Prostate Cancer Cells”
Veröffentlicht: (2025)

Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume
von: Elizabeth Robinson, et al.
Veröffentlicht: (2025)

Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
von: Tatsuya Shimomura, et al.
Veröffentlicht: (2026)

EXPRESSION OF CONCERN: Functional p53 Determines Docetaxel Sensitivity in Prostate Cancer Cells
Veröffentlicht: (2026)

In Vivo Efficacy of a Macrocyclic Peptoid‐Peptide Hybrid That Selectively Modulates the Beta‐Catenin/TCF Interaction to Inhibit Prostate Cancer
von: Justine Habault, et al.
Veröffentlicht: (2025)

Evidence and Rationale for Prostate Cancer Screening
von: Takeshi Takahashi
Veröffentlicht: (2025)

Prostate Cancer Cells With the AR‐Low and EMT‐High Phenotype Are Vulnerable to NAD+ Synthesis Inhibitors
von: Hyun‐Kyung Ko, et al.
Veröffentlicht: (2025)

The Infiltration of IL‐18‐Related Immune Cells and Their Bidirectional Regulatory Roles in the Pathogenesis of Prostate Cancer
von: Yuqi Liu, et al.
Veröffentlicht: (2025)

Castration Resistance Accelerates Prostate Cancer Kinetics
von: Sheila Jonnatan, et al.
Veröffentlicht: (2026)

Altered Glycosylation of PSA in Prostate Cancer Tissue
von: Hannu Koistinen, et al.
Veröffentlicht: (2025)

CHARGE: The “Big Questions” in Prostate Cancer for 2024
von: Andrea K. Miyahira, et al.
Veröffentlicht: (2024)

Correction to “Resveratrol Inhibits the Tumor Migration and Invasion by Upregulating TET1 and Reducing TIMP2/3 Methylation In Prostate Carcinoma Cells”
Veröffentlicht: (2025)

LIAS Promotes Cuproptosis in Prostate Cancer Cells by Suppressing Glycolysis via the p53 Signaling Pathway
von: Zhe Tang, et al.
Veröffentlicht: (2025)

Surveillance Versus Treatment for Favorable Intermediate‐Risk Prostate Cancer and Mortality‐Risk
von: Mutlay Sayan, et al.
Veröffentlicht: (2026)

The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate
von: Yifu Shi, et al.
Veröffentlicht: (2025)

Erratum to “Differential Impact of Paired Patient‐Derived BPH and Normal Adjacent Stromal Cells on Benign Prostatic Epithelial Cell Growth in 3D Culture”
Veröffentlicht: (2025)

Developments in Ultrasound‐Based Imaging for Prostate Cancer Detection
von: Reid Vassallo, et al.
Veröffentlicht: (2025)

Factors Associated With Male Breast Cancer Incidence Among Prostate Cancer Survivors: Real World Evidence From Veterans Affairs National Prostate Cancer Data Core
von: Erum Z. Whyne, et al.
Veröffentlicht: (2025)

Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms
von: Charly Bâcle, et al.
Veröffentlicht: (2025)

The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models
von: Haotian Chen, et al.
Veröffentlicht: (2025)

MEIS2 Modulates Oxidative Phosphorylation and ROS Generation to Affect CD8 + T Cell Antitumor Immunity in Prostate Cancer
von: Dengjun Han, et al.
Veröffentlicht: (2025)